Development of AVID100, a novel antibody-drug conjugate for the treatment of EGFR expressing solid tumors

被引：4
|
作者：
O'Connor-McCourt, M. [1 ]
Koropatnick, J. [2 ]
Maleki, S. [2 ]
Figueredo, R. [2 ]
Tikhomirov, I. [3 ]
Jaramillo, M. [4 ]
机构：
[1] Format Biol, R&D, Montreal, PQ, Canada
[2] Lawson Hlth Res Inst, Canc Res Program, London, ON, Canada
[3] Format Biol, R&D, Houston, TX USA
[4] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 69卷
关键词：
D O I：
10.1016/S0959-8049(16)33037-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
450
引用
收藏
页码：S147 / S147
页数：1
相关论文
共 50 条
  • [21] SGN-CD228A: A novel humanized anti-CD228 antibody-drug conjugate for the treatment of solid tumors
    Sandall, Sharsti L.
    Mason, Marsha
    Olson, Devra
    Mazahreh, Rebecca
    Sahetya, Disha
    Westendorf, Lori
    Leiske, Chris
    Schimpf, Brian
    Nguyen, Liem
    Katepalli, Madhu
    Trueblood, Esther
    Hale, Christopher
    Nesterova, Albina
    Wall, Jason
    Lewis, Timothy S.
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Optimizing peptide-drug conjugate delivery as an alternative to antibody-drug conjugates for solid tumors
    Sottero, Theo L.
    Girard, Emily J.
    Myers, Carrie H.
    Olson, James M.
    CANCER RESEARCH, 2017, 77
  • [23] Novel targets for antibody-drug conjugate therapy
    Grandi, A. G.
    Campagnoli, S. C.
    Parri, M. P.
    De Camilli, E. D. C.
    Jin, B. J.
    Sarmientos, P. S.
    Grandi, G. G.
    Terracciano, L. T.
    Pileri, P. P.
    Viale, G. V.
    Grifantini, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 41 - 41
  • [24] Antibody-drug conjugate drug development: where are the challenges?
    Wright, Laura
    Baughman, Sharon
    Wake, Ashleigh
    BIOANALYSIS, 2013, 5 (12) : 1467 - 1469
  • [25] Preclinical development of ADCT-211, a novel pyrrolobenzodiazepine dimer-based antibody-drug conjugate targeting solid tumors expressing IL13RA2
    Zammarchi, Francesca
    Havenith, Karin
    Leatherdale, Ben
    Roberts, Britanny
    Montolio, Lara
    Patel, Afroze
    Janghra, Narinder
    Alves, Pedro
    Zaitseva, Kristina
    Kirby, Cecile Oblette Ian
    de Haan, Lolke
    van Berkel, Patrick H.
    CANCER RESEARCH, 2023, 83 (07)
  • [26] A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies
    Kim, S. Y.
    Theunissen, J-W
    Balibalos, J.
    Liao-Chan, S.
    Babcock, M. C.
    Wong, T.
    Cairns, B.
    Gonzalez, D.
    van der Horst, E. H.
    Perez, M.
    Levashova, Z.
    Chinn, L.
    D'Alessio, J. A.
    Flory, M.
    Bermudez, A.
    Jackson, D. Y.
    Ha, E.
    Monteon, J.
    Bruhns, M. F.
    Chen, G.
    Migone, T-S
    BLOOD CANCER JOURNAL, 2015, 5 : e316 - e316
  • [27] Stepping forward in antibody-drug conjugate development
    Jin, Yiming
    Schladetsch, Megan A.
    Huang, Xueting
    Balunas, Marcy J.
    Wiemer, Andrew J.
    PHARMACOLOGY & THERAPEUTICS, 2022, 229
  • [28] CKD-703, a novel antibody-drug conjugate targeting cMET with an enhanced therapeutic index in solid tumors
    Lee, Kwanwoo
    Kim, Sue-Youn
    Hong, Hye-Jin
    Park, Eunjeong
    Park, Jungok
    Hong, Seong-Ho
    Bae, Daekwon
    Ha, Nina
    Yeon, Sohn-Ji
    Hwang, Inchang
    Kim, Semi
    Lee, Yoonseok
    Lee, Ju-Hee
    CANCER RESEARCH, 2024, 84 (07)
  • [29] Hot topics in antibody-drug conjugate development
    Thudium, Karen
    Bilic, Sanela
    BIOANALYSIS, 2013, 5 (24) : 2989 - 2993
  • [30] Development of Novel Glucocorticoid as Immunology Antibody-Drug Conjugate Payload for the Treatment of Autoimmune and Inflammatory Diseases
    Chai, Xiaojuan
    Fu, Yayuan
    Liu, Lifeng
    Yan, Yuxi
    Zhao, Quan
    Liu, Xiaoqing
    Zou, Yixin
    Dai, Jing
    Tang, Feng
    Cao, Zhuoxiao
    Tang, Renhong
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1177 - 1178
12345